The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

These indicators, known as ‘biomarkers’ – which include proteins, chemicals and other molecules that indicate normal or ...

New research reveals Parkinson’s disease may originate in the kidneys, where toxic protein buildup travels to the brain—offering fresh hope for early detection and treatment.

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

The primary pathogenic identifiers of Parkinson's disease include the progressive loss of dopaminergic neurons (DNs) in the substantia nigra and the creation of Lewy bodies. Studies have shown that ...

Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinson's drug levodopa doesn't work equally well for everyone. By mapping patients' brain ...